My interpretation is that a couple of patients may have had to oull out for reasons not associated with the study. They have pounced on an opportunity to replace these patients so the outcomes aren't affected...just my opinion and happy to wait it out..
Lok
- Forums
- ASX - By Stock
- Ann: Allowance of Canadian Patent on ATL1103 & Development Update
My interpretation is that a couple of patients may have had to...
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.3¢ |
Change
-0.002(2.35%) |
Mkt cap ! $86.05M |
Open | High | Low | Value | Volume |
8.5¢ | 8.6¢ | 8.3¢ | $72.87K | 861.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 204125 | 8.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.4¢ | 97200 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 204125 | 0.082 |
3 | 287000 | 0.081 |
10 | 935186 | 0.080 |
6 | 413817 | 0.079 |
6 | 689399 | 0.078 |
Price($) | Vol. | No. |
---|---|---|
0.084 | 97200 | 5 |
0.085 | 280000 | 3 |
0.086 | 96543 | 1 |
0.088 | 27962 | 1 |
0.089 | 200000 | 1 |
Last trade - 15.50pm 13/11/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online